Hims Hers Health Inc

For the period ended Dec 31, 2023. Filed Feb 26, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 26, 2024

HIMS$19.13-16.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations and Comprehensive Loss

Consolidated Statements of

Operations and Comprehensive Loss

(In Thousands, Except Share and Per Share Data)

	Year Ended December 31,
	2023	2022	2021
Revenue	$872,000	$526,916	$271,878
Cost of revenue	157,051	118,194	67,384
Gross profit	714,949	408,722	204,494
Operating expenses:
Marketing	446,435	272,587	135,902
Operations and support	119,857	77,403	47,593
Technology and development	48,227	29,237	22,379
General and administrative	129,883	98,192	113,662
Total operating expenses	744,402	477,419	319,536
Loss from operations	(29,453)	(68,697)	(115,042)
Other income (expense):
Change in fair value of liabilities	(1,075)	70	3,802
Other income, net	8,957	2,918	445
Total other income, net	7,882	2,988	4,247
Loss before income taxes	(21,571)	(65,709)	(110,795)
(Provision) benefit for income taxes	(1,975)	31	3,136
Net loss	(23,546)	(65,678)	(107,659)
Other comprehensive income (loss)	153	(140)	(126)
Total comprehensive loss	$(23,393)	$(65,818)	$(107,785)
Net loss per share attributable to common stockholders:
Basic and diluted	$(0.11)	$(0.32)	$(0.58)
Weighted average shares outstanding:
Basic and diluted	209,344,712	204,516,120	186,781,537

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.